OnKure Therapeutics Inc. (OKUR) Statistics & Valuation Metrics - Stocknear

OnKure Therapeutics Inc.

NASDAQ: OKUR · Real-Time Price · USD
2.50
-0.04 (-1.57%)
At close: Sep 26, 2025, 1:14 PM

OnKure Therapeutics Statistics

Share Statistics

OnKure Therapeutics has 13.53M shares outstanding. The number of shares has increased by 304.15% in one year.

13.53M
304.15%
0.56%
88.98%
8.03M
3,458
4.16%

Short Selling Information

The latest short interest is 197.87K, so 1.46% of the outstanding shares have been sold short.

197.87K
1.46%
2.08%
3.29

Valuation Ratios

The PE ratio is -2.18 and the forward PE ratio is -0.74. OnKure Therapeutics's PEG ratio is -0.04.

-2.18
-0.74
0
51.6
1.1
-2.24
-0.04
Financial Ratio History

Enterprise Valuation

Currently the Enterprise Value (EV) is not available for OnKure Therapeutics.

n/a
n/a
n/a
n/a

Financial Position

The company has a current ratio of 10.73, with a Debt / Equity ratio of 0.01.

10.73
10.73
0.01
-0.02
-0.02
-181.29

Financial Efficiency

Return on Equity is n/a and Return on Invested Capital is n/a.

n/a
n/a
n/a
n/a
$-1.15M
46
0
n/a

Taxes

n/a
0%

Stock Price Statistics

The stock price has increased by -84.32% in the last 52 weeks. The beta is 0.43, so OnKure Therapeutics's price volatility has been higher than the market average.

0.43
-84.32%
2.47
4.09
49.75
83,033

Income Statement

n/a
-662K
-54.39M
-52.67M
-51.71M
-52.37M
-3.95
Full Income Statement

Balance Sheet

The company has 110.76M in cash and 1.08M in debt, giving a net cash position of 109.68M.

110.76M
1.08M
109.68M
-154.72M
86.07M
76.95M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -51.12M and capital expenditures -52K, giving a free cash flow of -51.17M.

-51.12M
-52K
-51.17M
-3.84
Full Cash Flow Statement

Margins

n/a
n/a
n/a
n/a
n/a
n/a
n/a

Dividends & Yields

OKUR does not appear to pay any dividends at this time.

n/a
n/a
n/a
n/a
n/a
n/a
Dividend Details

Analyst Forecast

The average price target for OKUR is $32.5, which is 1179.5% higher than the current price. The consensus rating is "Buy".

$32.5
1179.5%
Buy
4
Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

n/a
n/a
n/a
n/a

Stock Splits

The last stock split was on Oct 7, 2024. It was a backward split with a ratio of 1:10.

Oct 7, 2024
backward
1:10

Scores

-1.6
3